Biogen launches first safety test of experimental drug BIIB142
NCT ID NCT07133828
First seen Nov 01, 2025 · Last updated May 12, 2026 · Updated 22 times
Summary
This early-stage study is testing the safety of a new drug called BIIB142 in healthy adults. Researchers want to see how the body handles the drug and what side effects may occur. The study involves giving single or multiple doses to different groups and comparing them to a placebo. No treatment benefit is expected for participants.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
PPD Development, LP
RECRUITINGLas Vegas, Nevada, 89113, United States
Contact Phone: •••-•••-••••
Contact
Conditions
Explore the condition pages connected to this study.